Chen Fei, director of Yide Medical, resigned The company lost 7.2541 million in the first half of the year

On September 16, Yide Medical (839056) announced that the board of directors received the resignation report submitted by director Chen Fei on September 16, 2021, and the resignation took effect from September 16, 2021. The above-mentioned resigned person holds 0 shares of the company's shares, accounting for 0% of the company's share capital. Not the target of joint disciplinary action for untrustworthiness, and will no longer hold other positions in the company after resignation.

The announcement shows that due to personal reasons, he applied to resign as a director of the company. The resignation did not result in the number of members of the company's board of directors falling below the statutory minimum, the number of members of the company's board of supervisors falling below the statutory minimum, and the number of employee representative supervisors being less than one-third of the members of the board of supervisors.

Chen Fei's resignation will not adversely affect the company's production and operation.

According to the data of the digging shell network, Yide Medical is dominated by high-tech, electronic control and mechanical design, according to the development trend of the big health industry, the company has two major categories of products: First, the surgical microscope of minimally invasive medical treatment, the products cover ophthalmology, neurology and spine surgery, orthopedics, otorhinolaryngology and other fields and microsurgery peripheral supporting systems. Second, ophthalmic optometry "eye contact lens" products, including intraocular lenses and scleral lenses. In the first half of 2021, the company's net profit attributable to shareholders of listed companies was -7,254,104.76 yuan, compared with -1,297,878.72 yuan in the same period of the previous year, an increase in losses year-on-year.

This article originated from the digging shell network